ArticleCell research2026

Ursodeoxycholic acid enhances cancer radioimmunotherapy by releasing a human-biased FXR-TRIM22-STAT1 immune brake.

Xinyan Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.